• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在医学中建立基因组学的价值:IGNITE 实用临床试验网络。

Establishing the value of genomics in medicine: the IGNITE Pragmatic Trials Network.

机构信息

Duke Center for Applied Genomics & Precision Medicine, Duke University, Durham, NC, USA.

Department of Pharmacotherapy and Translational Research, College of Pharmacy, University of Florida, Gainesville, FL, USA.

出版信息

Genet Med. 2021 Jul;23(7):1185-1191. doi: 10.1038/s41436-021-01118-9. Epub 2021 Mar 29.

DOI:10.1038/s41436-021-01118-9
PMID:33782552
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8263480/
Abstract

PURPOSE

A critical gap in the adoption of genomic medicine into medical practice is the need for the rigorous evaluation of the utility of genomic medicine interventions.

METHODS

The Implementing Genomics in Practice Pragmatic Trials Network (IGNITE PTN) was formed in 2018 to measure the clinical utility and cost-effectiveness of genomic medicine interventions, to assess approaches for real-world application of genomic medicine in diverse clinical settings, and to produce generalizable knowledge on clinical trials using genomic interventions. Five clinical sites and a coordinating center evaluated trial proposals and developed working groups to enable their implementation.

RESULTS

Two pragmatic clinical trials (PCTs) have been initiated, one evaluating genetic risk APOL1 variants in African Americans in the management of their hypertension, and the other to evaluate the use of pharmacogenetic testing for medications to manage acute and chronic pain as well as depression.

CONCLUSION

IGNITE PTN is a network that carries out PCTs in genomic medicine; it is focused on diversity and inclusion of underrepresented minority trial participants; it uses electronic health records and clinical decision support to deliver the interventions. IGNITE PTN will develop the evidence to support (or oppose) the adoption of genomic medicine interventions by patients, providers, and payers.

摘要

目的

将基因组医学纳入医疗实践的一个关键差距是需要严格评估基因组医学干预措施的效用。

方法

实施基因组医学实践实用临床试验网络(IGNITE PTN)于 2018 年成立,旨在衡量基因组医学干预措施的临床效用和成本效益,评估在不同临床环境中实际应用基因组医学的方法,并就使用基因组干预措施进行临床试验产生可推广的知识。五个临床站点和一个协调中心评估了试验提案并成立了工作组以使其得以实施。

结果

已经启动了两项实用临床试验(PCT),一项评估了非裔美国人高血压管理中遗传风险 APOL1 变异,另一项评估了药物遗传学检测在治疗急性和慢性疼痛以及抑郁症方面的应用。

结论

IGNITE PTN 是一个开展基因组医学实用临床试验的网络;它专注于多样性和代表性不足的少数族裔试验参与者的纳入;它使用电子健康记录和临床决策支持来提供干预措施。IGNITE PTN 将为患者、提供者和支付者采用基因组医学干预措施提供支持(或反对)的证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a97/8263480/02faeb59568c/nihms-1689965-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a97/8263480/ce310a24ff83/nihms-1689965-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a97/8263480/02faeb59568c/nihms-1689965-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a97/8263480/ce310a24ff83/nihms-1689965-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6a97/8263480/02faeb59568c/nihms-1689965-f0002.jpg

相似文献

1
Establishing the value of genomics in medicine: the IGNITE Pragmatic Trials Network.在医学中建立基因组学的价值:IGNITE 实用临床试验网络。
Genet Med. 2021 Jul;23(7):1185-1191. doi: 10.1038/s41436-021-01118-9. Epub 2021 Mar 29.
2
The IGNITE network: a model for genomic medicine implementation and research.IGNITE网络:基因组医学实施与研究的一个模型。
BMC Med Genomics. 2016 Jan 5;9:1. doi: 10.1186/s12920-015-0162-5.
3
Opportunities to implement a sustainable genomic medicine program: lessons learned from the IGNITE Network.实施可持续基因组医学计划的机会:来自 IGNITE 网络的经验教训。
Genet Med. 2019 Mar;21(3):743-747. doi: 10.1038/s41436-018-0080-y. Epub 2018 Jul 12.
4
Challenges and strategies for implementing genomic services in diverse settings: experiences from the Implementing GeNomics In pracTicE (IGNITE) network.在不同环境中实施基因组服务的挑战与策略:来自“实践中实施基因组学(IGNITE)”网络的经验
BMC Med Genomics. 2017 May 22;10(1):35. doi: 10.1186/s12920-017-0273-2.
5
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
6
Lessons Learned When Introducing Pharmacogenomic Panel Testing into Clinical Practice.将药物基因组学检测引入临床实践中的经验教训。
Value Health. 2017 Jan;20(1):54-59. doi: 10.1016/j.jval.2016.08.727. Epub 2016 Oct 21.
7
Developing a common framework for evaluating the implementation of genomic medicine interventions in clinical care: the IGNITE Network's Common Measures Working Group.制定一个评估基因组医学干预措施在临床护理中实施情况的通用框架:IGNITE 网络的通用措施工作组。
Genet Med. 2018 Jun;20(6):655-663. doi: 10.1038/gim.2017.144. Epub 2017 Sep 14.
8
Pragmatic Trials in Genomic Medicine: The Integrating Pharmacogenetics In Clinical Care (I-PICC) Study.基因组医学中的实用临床试验:整合药物基因组学于临床照护(I-PICC)研究。
Clin Transl Sci. 2020 Mar;13(2):381-390. doi: 10.1111/cts.12723. Epub 2019 Dec 18.
9
Stakeholder engagement: a key component of integrating genomic information into electronic health records.利益相关者的参与:将基因组信息整合到电子健康记录中的关键组成部分。
Genet Med. 2013 Oct;15(10):792-801. doi: 10.1038/gim.2013.127. Epub 2013 Sep 12.
10
What will it take to implement genomics in practice? Lessons from the IGNITE Network.要将基因组学付诸实践需要什么?来自 IGNITE 网络的经验教训。
Per Med. 2019 Jul;16(4):259-261. doi: 10.2217/pme-2019-0021. Epub 2019 Jul 23.

引用本文的文献

1
The Dietary Biomarkers Development Consortium: An Initiative for Discovery and Validation of Dietary Biomarkers for Precision Nutrition.膳食生物标志物开发联盟:一项用于发现和验证精准营养膳食生物标志物的倡议。
Curr Dev Nutr. 2025 Apr 5;9(5):107435. doi: 10.1016/j.cdnut.2025.107435. eCollection 2025 May.
2
Implementing a pragmatic clinical trial to tailor opioids for chronic pain on behalf of the IGNITE ADOPT PGx investigators.代表 IGNITE ADOPT PGx 研究者实施一项实用临床试验,以针对慢性疼痛调整阿片类药物。
Clin Transl Sci. 2024 Aug;17(8):e70005. doi: 10.1111/cts.70005.
3
Development of a Multifaceted Program for Pharmacogenetics Adoption at an Academic Medical Center: Practical Considerations and Lessons Learned.
制定一个综合性的药物基因组学采用计划,在学术医疗中心:实际考虑和经验教训。
Clin Pharmacol Ther. 2024 Oct;116(4):914-931. doi: 10.1002/cpt.3402. Epub 2024 Aug 21.
4
Bridging the Gap in Genomic Implementation: Identifying User Needs for Precision Nephrology.弥合基因组学应用差距:确定精准肾脏病学的用户需求。
Kidney Int Rep. 2024 Jun 3;9(8):2420-2431. doi: 10.1016/j.ekir.2024.05.032. eCollection 2024 Aug.
5
Rationale and design for a pragmatic randomized trial to assess gene-based prescribing for SSRIs in the treatment of depression.为评估基于基因的 SSRIs 处方治疗抑郁症的实用性随机试验的原理和设计。
Clin Transl Sci. 2024 Jun;17(6):e13822. doi: 10.1111/cts.13822.
6
Using implementation science to evaluate a population-wide genomic screening program: Findings from the first 20,000 In Our DNA SC participants.利用实施科学评估全人群基因组筛查计划:来自前 20000 名 In Our DNA SC 参与者的研究结果。
Am J Hum Genet. 2024 Mar 7;111(3):433-444. doi: 10.1016/j.ajhg.2024.01.004. Epub 2024 Feb 1.
7
Use of a multi-phased approach to identify and address facilitators and barriers to the implementation of a population-wide genomic screening program.采用多阶段方法来识别和解决实施全人群基因组筛查项目的促进因素和障碍。
Implement Sci Commun. 2023 Oct 11;4(1):122. doi: 10.1186/s43058-023-00500-9.
8
Genomic medicine to reduce tobacco and related disorders: Translation to precision prevention and treatment.基因组医学用于减少烟草及相关疾病:向精准预防与治疗的转化。
Addict Neurosci. 2023 Sep;7. doi: 10.1016/j.addicn.2023.100083. Epub 2023 Apr 1.
9
An Introductory Tutorial on Cardiovascular Pharmacogenetics for Healthcare Providers.心血管药物遗传学简介——供医疗保健提供者使用。
Clin Pharmacol Ther. 2023 Aug;114(2):275-287. doi: 10.1002/cpt.2957. Epub 2023 Jun 12.
10
Case Report: Performing a Medication Safety Review Assisted by Pharmacogenomics to Explain a Prescribing Cascade Resulting in a Patient Fall.病例报告:通过药物基因组学进行药物安全审查,以解释导致患者跌倒的处方级联现象。
Medicina (Kaunas). 2023 Jan 6;59(1):118. doi: 10.3390/medicina59010118.